Analyzes circulating cell-free DNA in blood for cancer-associated molecular signals, including DNA methylation and fragmentomic patterns, using next-generation sequencing and machine-learning algorithms.
Used as a multi-cancer early detection screening test to identify signals associated with selected cancers in people without symptoms. A positive result does not diagnose cancer and requires further clinical evaluation and confirmatory testing.